Analog Devices Inc. (NASDAQ: ADI) has raised its quarterly dividend by 8% to $0.99 per share, marking its 21st consecutive annual increase. The dividend is payable on March 17 to shareholders of record as of March 4.
The semiconductor giant also authorized an additional $10 billion in share repurchases, bringing its total buyback authorization to approximately $11.5 billion. Stock repurchases may be executed through open-market transactions or privately negotiated deals, with timing and volume at management’s discretion.
CEO Vincent Roche emphasized ADI’s commitment to delivering long-term shareholder value, citing the company’s ability to return 100% of free cash flow while maintaining growth investments. Over the past 21 years, ADI has distributed over $13 billion in dividends and repurchased roughly $16 billion in stock.
This move underscores ADI’s confidence in its financial stability, cash flow strength, and growth trajectory, reinforcing its position as a leader in the semiconductor industry.


Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



